News

Queensland researchers have discovered why potentially deadly cancers may be resistant to immunotherapy in a breakthrough ...
Pfizer Inc. today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care (SOC) Bacillus ...
Essential antioxidants and immune-boosting elements abound in Tonic Greens' 6-in-1 mix. It is a nutritional supplement ...
Research in Mayo Clinic's Liver Disease Immunobiology Lab led by Petra Hirsova, Pharm.D., Ph.D., focuses on metabolic dysfunction-associated steatohepatitis.